← Back to Search

Intravenous Nutrition for Low Birth Weight Infants

N/A

Waitlist Available

Research Sponsored by National Center for Research Resources (NCRR)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Clinically stable, very low birth weight infants (750-1,500 grams)

No prior insulin

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is testing different combinations of amino acids, fat, and sugar to see which best helps very low birth weight infants maintain normal blood sugar levels.

Who is the study for?

This trial is for clinically stable, very low birth weight infants (750-1,500 grams) with normal acid-base balance and blood sugar levels. It's open to those who haven't received insulin and need less than 30% oxygen supply. Infants with malformations, discernible diseases, or a history of sepsis cannot participate.Check my eligibility

What is being tested?

The study investigates how different combinations of nutrients given by IV affect the ability of very low birth weight infants to maintain normal blood sugar levels. It focuses on the breakdown of amino acids, fat, and sugars in these infants.See study design

What are the potential side effects?

Since this trial involves nutritional support rather than drugs, side effects may include imbalances in electrolytes or glucose levels due to the particular mixtures used but will be closely monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My baby was born weighing between 750 and 1,500 grams and is now stable.

Select...

I have never used insulin.

Select...

I do not have sepsis.

Select...

I need less than 30% supplemental oxygen.

Select...

I do not have any noticeable health conditions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Center for Research Resources (NCRR)Lead Sponsor

537 Previous Clinical Trials

316,920 Total Patients Enrolled

Baylor College of MedicineOTHER

1,001 Previous Clinical Trials

6,002,084 Total Patients Enrolled

Agneta L. SunehagStudy ChairBaylor College of Medicine

Media Library

Intravenous Infusion Clinical Trial Eligibility Overview. Trial Name: NCT00005889 — N/A

High Blood Sugar Clinical Trial 2023: Intravenous Infusion Highlights & Side Effects. Trial Name: NCT00005889 — N/A

Intravenous Infusion 2023 Treatment Timeline for Medical Study. Trial Name: NCT00005889 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does my profile match the criteria for this research investigation?

"This study seeks 96 infants aged between 4 Days and 6 Days with hyperglycemia. Additional inclusion criteria include: clinical stability, birth weights ranging from 750-1,500 grams, absence of prior insulin therapy, no congenital malformations, and the lack of any other discernible illnesses."

Answered by AI

Is geriatric participation welcome in this experiment?

"Applicants eligible to participate in this clinical trial must be between the ages of 4 Days and 6 Days. There are 65 studies available for children under 18, as well as 137 trials catered towards seniors over 65 years old."

Answered by AI

Are applicants currently being considered for this research program?

"This clinical trial, which was posted in October 1999 and modified June 2005, is no longer enrolling participants. Nevertheless, 241 other medical studies are actively seeking patients at the present moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion

1999. "Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00005889.

All > Texas